loadpatents
name:-0.0055830478668213
name:-0.0013589859008789
name:-0.00059294700622559
Loebel; Antony D. Patent Filings

Loebel; Antony D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Loebel; Antony D..The latest application filed is for "lurasidone novel dosage regimens and use thereof for the treatment, prevention, and/or management of at least one cns disorder".

Company Profile
0.1.6
  • Loebel; Antony D. - Larchmont NY
  • Loebel; Antony D - Larchmont NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Dosage of dasotraline and method for treatment of ADHD
Grant 10,076,503 - Loebel , et al. September 18, 2
2018-09-18
Lurasidone Novel Dosage Regimens And Use Thereof For The Treatment, Prevention, And/or Management Of At Least One Cns Disorder
App 20180092909 - Loebel; Antony D.
2018-04-05
Methods And Compositions Of Dasotraline For Treatment Of Adhd
App 20170266133 - LOEBEL; Antony D. ;   et al.
2017-09-21
Dosage Of Dasotraline And Method For Treatment Of Adhd
App 20170266134 - LOEBEL; Antony D. ;   et al.
2017-09-21
Lurasidone Novel Dosage Regimens And Use Thereof For The Treatment, Prevention, And/or Management Of At Least One Cns Disorder
App 20140350029 - Loebel; Antony D
2014-11-27
Treatment And Management Of Cns Disorders
App 20140113912 - Loebel; Antony D. ;   et al.
2014-04-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed